fulvestrant has been researched along with Carcinoma in Situ in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexi, X; Bouwman, P; Dijcks, F; Jonkers, J; Klarenbeek, S; Liu, X; van de Ven, M; van der Burg, E; Zwart, W | 1 |
Bundred, NJ; Gandhi, A; Holland, PA; Knox, WF; Potten, CS | 1 |
2 other study(ies) available for fulvestrant and Carcinoma in Situ
Article | Year |
---|---|
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
Topics: Animals; BRCA1 Protein; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Drug Implants; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Fulvestrant; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Transgenic; Ovariectomy; Progesterone; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Proteins | 2018 |
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma in Situ; Cell Division; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Transplantation; Receptors, Estrogen; Transplantation, Heterologous | 2000 |